Vaccine mandates generally have their basis in federal recommendations from the Centers for Disease Control and Prevention (CDC).
Most Americans believe that the CDC’s guidelines are carefully crafted, based upon unbiased and thorough scientific research, and
that they will keep us safe. This narrative isn’t necessarily true.
Because of their misplaced faith in this federal agency, most people assume there is no need to push back against federal narratives
on vaccines or against anticipated federal vaccine mandates. In his important new book, Vaccines - A Reappraisal
, Richard Moskowitz, M.D.,
provides information which should thoroughly refute these assumptions.
Dr. Moskowitz is a family physician who received his BA from Harvard, Phi Beta Kappa, his M.D. from New York University, and a U.S. Steel
Fellowship in philosophy at the University of Colorado. He has been in private practice since 1967 and, with over fifty years of experience,
he is intimately familiar with the potential impact of vaccines upon patients. In his easily digestible book, he examines vaccines and current
policy regarding them and provides extensive scientific information which should cast doubt upon the assumptions that they are safe,
necessary and effective.
Dr. Moskowitz explains that, in 1986, as a result of Congress’ passage of the National Childhood Vaccine Injury Act, liability was removed
from vaccine manufacturers for harm caused by vaccines. As he explains, a special process known as the “Vaccine Court” was established,
with rules uniquely applicable to the vaccine industry, making it extremely difficult for claimants to prevail and receive an award of damages.
Any damages awarded are paid by the public, through tax dollars. Dr. Moskowitz also explains that the number of vaccines recommended
by the vaccine industry, and the CDC, has continued to escalate following the removal of liability from manufacturers. In light of being
shielded from liability, something not afforded to other industries, there is simply no downside to the vaccine industry pressing for more
(Read the rest of the article